Omega-3 May Improve Quality of Life for Pancreatic Cancer Patients

pancreatic cancer

The addition of intravenous omega-3 fatty acids to anti-tumor medications for pancreatic cancer may improve quality of life (QOL) and clinical response, according to researchers from the University Hospitals of Leicester, UK. The authors report that the first clinical trial of intravenous (IV) ω-3FAs as a therapeutic agent in anyRead …

Read moreOmega-3 May Improve Quality of Life for Pancreatic Cancer Patients